Finance

Lists
Why is BMEA up 3,47%?
Dive Deeper
BMEA:NASDAQ
Biomea Fusion Inc
1,49 $
+3,47%
(+0,050) 1D
1,48 $
-0,67% (-0,0100)
After hours
Closed: 24 қыр., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMEA...
Open
1,46 $
High
1,50 $
Low
1,39 $
Mkt. cap
108,00 млн
Avg. vol.
2,22 млн
Volume
0,00
52-wk high
2,99 $
52-wk low
0,87 $
EPS
-0,50 $
Beta
-0,23
Shares outstanding
72,48 млн
No. of employees
37
Open
1,46 $
High
1,50 $
Low
1,39 $
Mkt. cap
108,00 млн
Avg. vol.
2,22 млн
Volume
0,00
52-wk high
2,99 $
52-wk low
0,87 $
EPS
-0,50 $
Beta
-0,23
Shares outstanding
72,48 млн
No. of employees
37
News stories
From web sources and news partners
About Biomea Fusion Inc
CEO-
Employees37
Founded2017
HeadquartersSan Carlos, Калифорния, Америка Құрама Штаттары
Sector-
Websitebiomeafusion.com
Analyst ratings
Based on 5 analysts giving stock ratings to BMEA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BMEA in the last 3 months.
Highest
Current 1,49 $
9,00 $ (+504,03%)
Average
6,80 $ (+356,38%)
Lowest
4,00 $ (+168,46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
4,00 $
+168,5%
08/24/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
7,00 $
+369,8%
08/14/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
7,00 $
+369,8%
08/10/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
7,00 $
+369,8%
08/06/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
9,00 $
+504%
08/06/2026
Anupam Rama
J.P. Morgan
Sell
Maintained
-
-
03/24/2026
Last report
2026 ж. 05 там.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,12 $ / -0,23 $
+48,07%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14,40 млн
8,12 млн
9,12 млн
9,14 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,20 млн
3,60 млн
3,65 млн
3,62 млн
Operating expense
18,60 млн
11,72 млн
12,77 млн
12,77 млн
Total operating expenses
18,60 млн
11,72 млн
12,77 млн
12,77 млн
Operating income
-18,60 млн
-11,72 млн
-12,77 млн
-12,77 млн
Other non operating income
-
19,86 млн
-581,00 м.
4,12 млн
EBT including unusual items
-16,41 млн
4,61 млн
-12,42 млн
-8,33 млн
EBT excluding unusual items
-14,20 млн
4,61 млн
-12,92 млн
-8,33 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16,41 млн
4,61 млн
-12,42 млн
-8,33 млн
Net profit margin
-
-
-
-
Earnings per share
-0,24
-0,12
-0,17
-0,17
Interest and investment income
4,40 млн
-
430,00 м.
319,00 м.
Interest expense
-
-3,53 млн
-
-
Net interest expenses
4,40 млн
-3,53 млн
430,00 м.
319,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-18,17 млн
-11,67 млн
-12,73 млн
-12,75 млн
Gain or loss from assets sale
-
-
-510,00 м.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары